Birchall, Jonathan R., Robert K. Irwin, Panayiotis Nikolaou, Aaron M. Coffey, Bryce E. Kidd, Megan Murphy, Michael Molway, et al. “XeUS: A Second-Generation Automated Open-Source Batch-Mode Clinical-Scale Hyperpolarizer.” Journal of Magnetic Resonance 319 (October 2020): 106813.
We present a second-generation open-source automated batch-mode 129Xe hyperpolarizer (XeUS GEN2), designed for clinical-scale hyperpolarized (HP) 129Xe production via spin-exchange optical pumping (SEOP) in the regimes of high Xe density (0.66–2.5 atm partial pressure) and resonant photon ﬂux (~170 W, Dk = 0.154 nm FWHM), without the need for cryo-collection typically employed by continuous-ﬂow hyperpolarizers. An Arduino micro-controller was used for hyperpolarizer operation. Processing open-source software was employed to program a custom graphical user interface (GUI), capable of remote automation. The Arduino Integrated Development Environment (IDE) was used to design a variety of customized automation sequences such as temperature ramping, NMR signal acquisition, and SEOP cell reﬁlling for increased reliability. A polycarbonate 3D-printed oven equipped with a thermoelectric cooler/heater provides thermal stability for SEOP for both binary (Xe/N2) and ternary (4He-containing) SEOP cell gas mixtures. Quantitative studies of the 129Xe hyperpolarization process demonstrate that near-unity polarization can be achieved in a 0.5 L SEOP cell. For example, %PXe of 93.2 ± 2.9% is achieved at 0.66 atm Xe pressure with polarization build-up rate constant cSEOP = 0.040 ± 0.005 minÀ1, giving a max dose equivalent % 0.11 L/h 100% hyperpolarized, 100% enriched 129Xe; %PXe of 72.6 ± 1.4% is achieved at 1.75 atm Xe pressure with cSEOP of 0.041 ± 0.001 minÀ1, yielding a corresponding max dose equivalent of 0.27 L/h. Quality assurance studies on this device have demonstrated the potential to reﬁll SEOP cells hundreds of times without signiﬁcant losses in performance, with average %PXe = 71.7%, (standard deviation rP = 1.52%) and mean polarization lifetime T1 = 90.5 min, (standard deviation rT = 10.3 min) over the ﬁrst ~200 gas mixture reﬁlls, with sufﬁcient performance maintained across a further ~700 reﬁlls. These ﬁndings highlight numerous technological developments and have signiﬁcant translational relevance for efﬁcient production of gaseous HP 129Xe contrast agents for use in clinical imaging and bio-sensing techniques.